Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

PR2085b

High-density prostate cancer tissue array, including TNM, pathology grade, Gleason grade and Gleason scores, 114 cases/208 cores, replacing PR2085a
Price: $455.00 Add to Cart
Trial (PR2085bt*): $150.00 Add to Cart
H&E (PR2085bs*): $455.00 Add to Cart

Microarray Panel:High-density prostate adenocarcinoma tissue microarray, containing 92 cases of adenocarcinoma, 2 prostate transitional cell carcinoma, 12 prostate adjacent normal tissue and 8 normal prostate tissue, duplicate cores per case of cancer, single core per case of adjacent normal and normal tissue
Cores:208
Cases:114
Layout:16 cols × 13 rows
Core Diameter:1 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Gleason Grade Gleason Score TNM Type †
A1 1 76 M Prostate Adenocarcinoma 2 4 1+4 T2aNxM0 Malignant
A2 2 76 M Prostate Adenocarcinoma (sparse) 1 1 1+4 T2aNxM0 Malignant
A3 3 70 M Prostate Adenocarcinoma 1 1 1+3 T2aNxM0 Malignant
A4 4 70 M Prostate Adenocarcinoma 1 1 1+3 T2aNxM0 Malignant
A5 5 70 M Prostate Adenocarcinoma (hyperplasia) – 1 1+1 T1bNxM0 Malignant
A6 6 70 M Prostate Adenocarcinoma (hyperplasia) – 1 1+1 T1bNxM0 Malignant
A7 7 75 M Prostate Adenocarcinoma 1 1 1+1 T2bNxM0 Malignant
A8 8 75 M Prostate Adenocarcinoma 1 1 1+1 T2bNxM0 Malignant
A9 9 38 M Prostate Adenocarcinoma (prostate tissue) – – 1+1 T4NxM0 Malignant
A10 10 38 M Prostate Adenocarcinoma (prostate tissue) – – 1+1 T4NxM0 Malignant
A11 11 66 M Prostate Prostate tissue with carcinomatous change – – 1+1 T1NxM0 Malignant
A12 12 66 M Prostate Adenocarcinoma (hyperplasia) – 1 1+1 T1NxM0 Malignant
A13 13 61 M Prostate Adenocarcinoma 2–3 1 2+3 T2NxM0 Malignant
A14 14 61 M Prostate Adenocarcinoma 2–3 1 2+3 T2NxM0 Malignant
A15 15 63 M Prostate Adenocarcinoma 1 1 2+5 T2NxM0 Malignant
A16 16 63 M Prostate Adenocarcinoma 1 3 2+5 T2NxM0 Malignant
B1 17 75 M Prostate Adenocarcinoma (blood vessle and smooth muscle tissue) – – 2+2 T4NxM0 Malignant
B2 18 75 M Prostate Adenocarcinoma (smooth muscle tissue) – – 2+2 T4NxM0 Malignant
B3 19 55 M Prostate Adenocarcinoma 1 1 2+2 T2NxM0 Malignant
B4 20 55 M Prostate Adenocarcinoma 1 1 2+2 T2NxM0 Malignant
B5 21 70 M Prostate Adenocarcinoma 1 1 2+3 T2NxM0 Malignant
B6 22 70 M Prostate Adenocarcinoma 1 1 2+3 T2NxM0 Malignant
B7 23 66 M Prostate Adenocarcinoma 1 1 2+2 T2NxM0 Malignant
B8 24 66 M Prostate Adenocarcinoma 1 1 2+2 T2NxM0 Malignant
B9 25 61 M Prostate Adenocarcinoma 2 2 2+2 T2NxM0 Malignant
B10 26 61 M Prostate Adenocarcinoma 2 2 2+2 T2NxM0 Malignant
B11 27 75 M Prostate Adenocarcinoma (prostate tissue with carcinomatous change) – 4 2+3 T2NxM0 Malignant
B12 28 75 M Prostate Adenocarcinoma (prostate tissue with carcinomatous change) – 4 2+3 T2NxM0 Malignant
B13 29 60 M Prostate Adenocarcinoma 2 1 2+3 T2NxM0 Malignant
B14 30 60 M Prostate Adenocarcinoma 2 1 2+3 T2NxM0 Malignant
B15 31 54 M Prostate Adenocarcinoma 2 2 2+2 T3NxM0 Malignant
B16 32 54 M Prostate Adenocarcinoma 2 2 2+2 T3NxM0 Malignant
C1 33 76 M Prostate Adenocarcinoma 2 3 1+2 T2NxM0 Malignant
C2 34 76 M Prostate Adenocarcinoma 2 2 1+2 T2NxM0 Malignant
C3 35 64 M Prostate Adenocarcinoma 2 3 3+3 T2NxM0 Malignant
C4 36 64 M Prostate Adenocarcinoma 2 3 3+3 T2NxM0 Malignant
C5 37 80 M Prostate Adenocarcinoma 3 2 4+2 T2NxM0 Malignant
C6 38 80 M Prostate Adenocarcinoma 3 3 4+2 T2NxM0 Malignant
C7 39 72 M Prostate Adenocarcinoma 2 2 2+2 T4NxM0 Malignant
C8 40 72 M Prostate Adenocarcinoma 2 2 2+2 T4NxM0 Malignant
C9 41 78 M Prostate Adenocarcinoma 2 3 2+3 T2NxM0 Malignant
C10 42 78 M Prostate Adenocarcinoma 2–3 3 2+3 T2NxM0 Malignant
C11 43 72 M Prostate Adenocarcinoma 2–3 4 2+3 T2NxM0 Malignant
C12 44 72 M Prostate Adenocarcinoma 3 2 2+3 T2NxM0 Malignant
C13 45 56 M Prostate Adenocarcinoma 3 – 2+2 T2NxM0 Malignant
C14 46 56 M Prostate Adenocarcinoma (hyperplasia) – 4 2+2 T2NxM0 Malignant
C15 47 64 M Prostate Adenocarcinoma 1 5 2+4 T2NxM0 Malignant
C16 48 64 M Prostate Adenocarcinoma 1 4 2+4 T2NxM0 Malignant
D1 49 65 M Prostate Adenocarcinoma 3 3 2+3 T2NxM0 Malignant
D2 50 65 M Prostate Adenocarcinoma 3 4 2+3 T2NxM0 Malignant
D3 51 69 M Prostate Adenocarcinoma 1 2 2+3 T3NxMo Malignant
D4 52 69 M Prostate Adenocarcinoma 1 2 2+3 T3NxMo Malignant
D5 53 73 M Prostate Adenocarcinoma 2 3 3+3 T2NxM0 Malignant
D6 54 73 M Prostate Adenocarcinoma 2 3 3+3 T2NxM0 Malignant
D7 55 70 M Prostate Adenocarcinoma 2 4 4+4 T2NxM0 Malignant
D8 56 70 M Prostate Adenocarcinoma 2 4 4+4 T2NxM0 Malignant
D9 57 69 M Prostate Adenocarcinoma 2 4 3+4 T2NxM0 Malignant
D10 58 69 M Prostate Adenocarcinoma 2 3 3+4 T2NxM0 Malignant
D11 59 69 M Prostate Adenocarcinoma 2 – 3+3 T2NxM0 Malignant
D12 60 69 M Prostate Adenocarcinoma 2 3 3+3 T2NxM0 Malignant
D13 61 69 M Prostate Adenocarcinoma 2 2 2+3 T3NxMo Malignant
D14 62 69 M Prostate Adenocarcinoma 2 2 2+3 T3NxMo Malignant
D15 63 69 M Prostate Adenocarcinoma 2–3 3 3+3 T2NxM0 Malignant
D16 64 69 M Prostate Adenocarcinoma 2–3 5 3+3 T2NxM0 Malignant
E1 65 74 M Prostate Adenocarcinoma 2 3 3+3 T2NxM0 Malignant
E2 66 74 M Prostate Adenocarcinoma 2 3 3+3 T2NxM0 Malignant
E3 67 82 M Prostate Adenocarcinoma 2 4 3+3 T2NxM0 Malignant
E4 68 82 M Prostate Adenocarcinoma 2 3 3+3 T2NxM0 Malignant
E5 69 62 M Prostate Adenocarcinoma 2 3 3+2 T2NxM0 Malignant
E6 70 62 M Prostate Adenocarcinoma 2 3 3+2 T2NxM0 Malignant
E7 71 64 M Prostate Adenocarcinoma 2 3 3+3 T2aNxM0 Malignant
E8 72 64 M Prostate Adenocarcinoma 2 3 3+3 T2aNxM0 Malignant
E9 73 81 M Prostate Adenocarcinoma 2 2 4+3 T3NxM0 Malignant
E10 74 81 M Prostate Adenocarcinoma 2 2 4+3 T3NxM0 Malignant
E11 75 70 M Prostate Adenocarcinoma (hyperplasia) – 3 3+3 T3NxM0 Malignant
E12 76 70 M Prostate Adenocarcinoma 2 3 3+3 T3NxM0 Malignant
E13 77 73 M Prostate Adenocarcinoma 2 3 3+3 T2NxM0 Malignant
E14 78 73 M Prostate Adenocarcinoma 2 3 3+3 T2NxM0 Malignant
E15 79 83 M Prostate Adenocarcinoma 2 3 3+4 T2NxM0 Malignant
E16 80 83 M Prostate Adenocarcinoma 2 3 3+4 T2NxM0 Malignant
F1 81 20 M Prostate Adenocarcinoma 2 3 3+3 T4NxM0 Malignant
F2 82 20 M Prostate Adenocarcinoma 2 3 3+3 T4NxM0 Malignant
F3 83 67 M Prostate Adenocarcinoma 2 3 4+3 T2NxM0 Malignant
F4 84 67 M Prostate Adenocarcinoma 2 3 4+3 T2NxM0 Malignant
F5 85 68 M Prostate Adenocarcinoma 2 – 2+3 T2NxM0 Malignant
F6 86 68 M Prostate Adenocarcinoma (sparse) – 5 2+3 T2NxM0 Malignant
F7 87 70 M Prostate Adenocarcinoma 2 3 3+3 T2NxM0 Malignant
F8 88 70 M Prostate Adenocarcinoma 2 3 3+3 T2NxM0 Malignant
F9 89 62 M Prostate Adenocarcinoma 2 4 3+3 T2NxM0 Malignant
F10 90 62 M Prostate Adenocarcinoma 2 4 3+3 T2NxM0 Malignant
F11 91 58 M Prostate Adenocarcinoma 2 4 3+3 T2NxM0 Malignant
F12 92 58 M Prostate Adenocarcinoma 2 3 3+3 T2NxM0 Malignant
F13 93 56 M Prostate Adenocarcinoma 2 – 3+4 T2NxM0 Malignant
F14 94 56 M Prostate Adenocarcinoma 3 3 3+4 T2NxM0 Malignant
F15 95 73 M Prostate Adenocarcinoma 1 3 2+2 T2NxM0 Malignant
F16 96 73 M Prostate Adenocarcinoma 1 3 2+2 T2NxM0 Malignant
G1 97 70 M Prostate Adenocarcinoma 2 5 3+4 T2NxM0 Malignant
G2 98 70 M Prostate Adenocarcinoma 2 3 3+4 T2NxM0 Malignant
G3 99 85 M Prostate Adenocarcinoma 2 3 3+3 T4NxM0 Malignant
G4 100 85 M Prostate Adenocarcinoma 2 3 3+3 T4NxM0 Malignant
G5 101 63 M Prostate Adenocarcinoma 2 2 3+4 T2NxM0 Malignant
G6 102 63 M Prostate Adenocarcinoma 2 4 3+4 T2NxM0 Malignant
G7 103 51 M Prostate Adenocarcinoma 3 4 4+3 T2NxM0 Malignant
G8 104 51 M Prostate Adenocarcinoma 3 3 4+3 T2NxM0 Malignant
G9 105 73 M Prostate Adenocarcinoma 3 4 4+3 T2NxM0 Malignant
G10 106 73 M Prostate Adenocarcinoma 3 5 4+3 T2NxM0 Malignant
G11 107 80 M Prostate Adenocarcinoma 2 2 5+3 T2NxM0 Malignant
G12 108 80 M Prostate Adenocarcinoma 2 3 5+3 T2NxM0 Malignant
G13 109 78 M Prostate Adenocarcinoma 2–3 3 4+4 T2NxM0 Malignant
G14 110 78 M Prostate Adenocarcinoma 2 3 4+4 T2NxM0 Malignant
G15 111 70 M Prostate Adenocarcinoma 2 3 2+3 T2NxM0 Malignant
G16 112 70 M Prostate Adenocarcinoma 2 4 2+3 T2NxM0 Malignant
H1 113 76 M Prostate Adenocarcinoma 3 4 4+4 T2NxM0 Malignant
H2 114 76 M Prostate Adenocarcinoma 3 5 4+4 T2NxM0 Malignant
H3 115 73 M Prostate Adenocarcinoma 3 4 5+4 T2NxM0 Malignant
H4 116 73 M Prostate Adenocarcinoma 3 4 5+4 T2NxM0 Malignant
H5 117 40 M Prostate Adenocarcinoma 3 – 4+4 T2NxM0 Malignant
H6 118 40 M Prostate Adenocarcinoma 3 4 4+4 T2NxM0 Malignant
H7 119 82 M Prostate Adenocarcinoma (sparse) 2 3 3+4 T2NxM0 Malignant
H8 120 82 M Prostate Adenocarcinoma 2 – 3+4 T2NxM0 Malignant
H9 121 73 M Prostate Adenocarcinoma 2 5 4+4 T2NxM0 Malignant
H10 122 73 M Prostate Adenocarcinoma 2 4 4+4 T2NxM0 Malignant
H11 123 64 M Prostate Adenocarcinoma 3 4 4+4 T2NxM0 Malignant
H12 124 64 M Prostate Adenocarcinoma 3 4 4+4 T2NxM0 Malignant
H13 125 70 M Prostate Adenocarcinoma 3 3 4+5 T2NxM0 Malignant
H14 126 70 M Prostate Adenocarcinoma – – 4+5 T2NxM0 Malignant
H15 127 60 M Prostate Adenocarcinoma 4 4 4+4 T2NxM0 Malignant
H16 128 60 M Prostate Adenocarcinoma 4 4 4+4 T2NxM0 Malignant
I1 129 76 M Prostate Adenocarcinoma 3 – 4+4 T2NxM0 Malignant
I2 130 76 M Prostate Adenocarcinoma 3 5 4+4 T2NxM0 Malignant
I3 131 72 M Prostate Adenocarcinoma 3 4 4+4 T2NxM0 Malignant
I4 132 72 M Prostate Adenocarcinoma 3 4 4+4 T2NxM0 Malignant
I5 133 65 M Prostate Adenocarcinoma 3 4 4+3 T2NxM0 Malignant
I6 134 65 M Prostate Adenocarcinoma 3 4 4+3 T2NxM0 Malignant
I7 135 57 M Prostate Adenocarcinoma 2 4 4+4 T2aNxM0 Malignant
I8 136 57 M Prostate Adenocarcinoma 2 3 4+4 T2aNxM0 Malignant
I9 137 73 M Prostate Adenocarcinoma 3 4 5+4 T2NxM0 Malignant
I10 138 73 M Prostate Adenocarcinoma 3 4 5+4 T2NxM0 Malignant
I11 139 63 M Prostate Adenocarcinoma 2 5 4+4 T2aNxM0 Malignant
I12 140 63 M Prostate Adenocarcinoma 2 5 4+4 T2aNxM0 Malignant
I13 141 55 M Prostate Adenocarcinoma 3 4 4+5 T2NxM0 Malignant
I14 142 55 M Prostate Adenocarcinoma 3 4 4+5 T2NxM0 Malignant
I15 143 60 M Prostate Adenocarcinoma 4 5 3+5 T2NxM0 Malignant
I16 144 60 M Prostate Adenocarcinoma 4 3 3+5 T2NxM0 Malignant
J1 145 82 M Prostate Adenocarcinoma 3 5 4+4 T2NxM0 Malignant
J2 146 82 M Prostate Adenocarcinoma 3 5 4+4 T2NxM0 Malignant
J3 147 72 M Prostate Adenocarcinoma 3 4 5+5 T2NxM0 Malignant
J4 148 72 M Prostate Adenocarcinoma 3 4 5+5 T2NxM0 Malignant
J5 149 67 M Prostate Adenocarcinoma 3 5 4+5 T2NxM0 Malignant
J6 150 67 M Prostate Adenocarcinoma 3 5 4+5 T2NxM0 Malignant
J7 151 87 M Prostate Adenocarcinoma 4 5 5+5 T2NxM0 Malignant
J8 152 87 M Prostate Adenocarcinoma 3 4 5+5 T2NxM0 Malignant
J9 153 60 M Prostate Adenocarcinoma 4 5 5+5 T2NxM0 Malignant
J10 154 60 M Prostate Adenocarcinoma 4 5 5+5 T2NxM0 Malignant
J11 155 87 M Prostate Adenocarcinoma 3 5 3+5 T2NxM0 Malignant
J12 156 87 M Prostate Adenocarcinoma 3 5 3+5 T2NxM0 Malignant
J13 157 72 M Prostate Adenocarcinoma 3 5 5+5 T2NxM0 Malignant
J14 158 72 M Prostate Adenocarcinoma 3 5 5+5 T2NxM0 Malignant
J15 159 75 M Prostate Adenocarcinoma 4 5 5+5 T3NxM0 Malignant
J16 160 75 M Prostate Adenocarcinoma 4 5 5+5 T3NxM0 Malignant
K1 161 62 M Prostate Adenocarcinoma with necrosis 4 5 5+5 T2NxM0 Malignant
K2 162 62 M Prostate Adenocarcinoma with necrosis 4 5 5+5 T2NxM0 Malignant
K3 163 72 M Prostate Adenocarcinoma 4 5 5+5 T2NxM0 Malignant
K4 164 72 M Prostate Adenocarcinoma 4 5 5+5 T2NxM0 Malignant
K5 165 70 M Prostate Adenocarcinoma 3 – 5+5 T2NxM0 Malignant
K6 166 70 M Prostate Adenocarcinoma 3 5 5+5 T2NxM0 Malignant
K7 167 62 M Prostate Adenocarcinoma 3 – 5+5 T2NxM0 Malignant
K8 168 62 M Prostate Adenocarcinoma (prostate tissue) – 5 5+5 T2NxM0 Malignant
K9 169 57 M Prostate Adenocarcinoma 4 5 5+5 T4NxM0 Malignant
K10 170 57 M Prostate Adenocarcinoma 4 5 5+5 T4NxM0 Malignant
K11 171 70 M Prostate Adenocarcinoma 4 5 5+5 T2NxM0 Malignant
K12 172 70 M Prostate Adenocarcinoma 3 4 5+5 T2NxM0 Malignant
K13 173 77 M Prostate Adenocarcinoma 3 3 5+3 T2NxM0 Malignant
K14 174 77 M Prostate Adenocarcinoma 3 3 5+3 T2NxM0 Malignant
K15 175 63 M Prostate Adenocarcinoma 3 5 5+4 T2aNxM0 Malignant
K16 176 63 M Prostate Adenocarcinoma 3 5 5+4 T2aNxM0 Malignant
L1 177 71 M Prostate Adenocarcinoma 3 5 5+4 T2NxM0 Malignant
L2 178 71 M Prostate Adenocarcinoma with necrosis (sparse) – 4 5+4 T2NxM0 Malignant
L3 179 78 M Prostate Adenocarcinoma 3 4 3+5 T2NxM0 Malignant
L4 180 78 M Prostate Adenocarcinoma 3 4 3+5 T2NxM0 Malignant
L5 181 71 M Prostate Adenocarcinoma 3 5 5+5 T2NxM0 Malignant
L6 182 71 M Prostate Adenocarcinoma 3 4 5+5 T2NxM0 Malignant
L7 183 66 M Prostate Adenocarcinoma 4 5 5+5 T2NxM Malignant
L8 184 66 M Prostate Adenocarcinoma 4 – 5+5 T2NxM0 Malignant
L9 185 66 M Prostate Transitional cell carcinoma 3 – – T4N0M1 Malignant
L10 186 66 M Prostate Transitional cell carcinoma – – – T4N0M1 Malignant
L11 187 79 M Prostate Transitional cell carcinoma 3 – – T2NxM0 Malignant
L12 188 79 M Prostate Transitional cell carcinoma (sparse) 3 – – T2NxM0 Malignant
L13 189 35 M Prostate Normal prostate tissue – – – – Normal
L14 190 43 M Prostate Normal prostate tissue – – – – Normal
L15 191 40 M Prostate Normal prostate tissue – – – – Normal
L16 192 30 M Prostate Normal prostate tissue – – – – Normal
M1 193 19 M Prostate Normal prostate tissue – – – – Normal
M2 194 40 M Prostate Normal prostate tissue – – – – Normal
M3 195 40 M Prostate Normal prostate tissue – – – – Normal
M4 196 30 M Prostate Normal prostate tissue – – – – Normal
M5 197 21 M Prostate Adjacent normal prostate tissue (blood vessle and smooth muscle tissue) – – – – NAT
M6 198 25 M Prostate Adjacent normal prostate tissue – – – – NAT
M7 199 63 M Prostate Adjacent normal prostate tissue – – – – NAT
M8 200 63 M Prostate Adjacent normal prostate tissue – – – – NAT
M9 201 72 M Prostate Adjacent normal prostate tissue – – – – NAT
M10 202 73 M Prostate Adjacent normal prostate tissue – – – – NAT
M11 203 70 M Prostate Adjacent normal prostate tissue – – – – NAT
M12 204 66 M Prostate Adjacent normal prostate tissue (hyperplasia) – – – – NAT
M13 205 66 M Prostate Adjacent normal prostate tissue – – – – NAT
M14 206 78 M Prostate Adjacent normal prostate tissue – – – – NAT
M15 207 75 M Prostate Adjacent normal prostate tissue (hyperplasia) – – – – NAT
M16 208 65 M Prostate Adjacent normal prostate tissue – – – – NAT

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal